Astrana Health, Inc. (NASDAQ:ASTH) Shares Sold by SteelPeak Wealth LLC

SteelPeak Wealth LLC lowered its position in shares of Astrana Health, Inc. (NASDAQ:ASTH) by 20.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 541,984 shares of the company’s stock after selling 138,000 shares during the period. Astrana Health makes up approximately 0.7% of SteelPeak Wealth LLC’s portfolio, making the stock its 28th largest position. SteelPeak Wealth LLC’s holdings in Astrana Health were worth $17,089,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. KBC Group NV increased its stake in Astrana Health by 108.4% during the fourth quarter. KBC Group NV now owns 2,530 shares of the company’s stock worth $80,000 after acquiring an additional 1,316 shares during the last quarter. Linden Thomas Advisory Services LLC grew its holdings in shares of Astrana Health by 23.3% during the 4th quarter. Linden Thomas Advisory Services LLC now owns 15,247 shares of the company’s stock worth $481,000 after purchasing an additional 2,883 shares during the period. Principal Financial Group Inc. acquired a new stake in shares of Astrana Health during the 3rd quarter worth about $13,383,000. Franklin Resources Inc. purchased a new stake in Astrana Health in the 3rd quarter valued at about $1,187,000. Finally, Hohimer Wealth Management LLC acquired a new position in Astrana Health in the third quarter valued at about $312,000. Hedge funds and other institutional investors own 52.77% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on ASTH shares. Robert W. Baird boosted their price target on shares of Astrana Health from $67.00 to $86.00 and gave the company an “outperform” rating in a research note on Wednesday, November 13th. Macquarie raised Astrana Health to a “hold” rating in a research report on Monday, December 16th. Truist Financial lowered their price target on Astrana Health from $59.00 to $50.00 and set a “buy” rating for the company in a research report on Monday, January 13th. KeyCorp began coverage on Astrana Health in a report on Friday, October 11th. They issued a “sector weight” rating on the stock. Finally, BTIG Research raised their target price on Astrana Health from $60.00 to $70.00 and gave the company a “buy” rating in a report on Thursday, October 3rd. Two equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, Astrana Health currently has a consensus rating of “Moderate Buy” and an average price target of $63.67.

Astrana Health Trading Up 0.6 %

NASDAQ:ASTH opened at $37.93 on Wednesday. Astrana Health, Inc. has a 12-month low of $29.08 and a 12-month high of $63.20. The firm has a market cap of $2.13 billion, a PE ratio of 29.18, a price-to-earnings-growth ratio of 1.46 and a beta of 1.20. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60. The stock has a fifty day moving average price of $36.56 and a 200 day moving average price of $46.58.

Astrana Health (NASDAQ:ASTH) last announced its quarterly earnings data on Thursday, November 7th. The company reported $0.33 EPS for the quarter, hitting analysts’ consensus estimates of $0.33. The business had revenue of $478.71 million during the quarter, compared to the consensus estimate of $462.01 million. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. During the same period in the previous year, the company posted $0.47 earnings per share. Sell-side analysts anticipate that Astrana Health, Inc. will post 1.15 earnings per share for the current fiscal year.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.